... References Parkinsonism — Cleveland Clinic Epidemiology, Pathogenesis, and Genetics of Parkinson Disease — Wolters Kluwer UpToDate Initial Pharmacologic Treatment of Parkinson Disease — Wolters Kluwer UpToDate Levodopa — Parkinson’s Foundation Device-Assisted and Lesioning Procedures for Parkinson Disease — Wolters Kluwer UpToDate COMT Inhibitors — ...
How To Treat Parkinson’s Disease and Parkinsonism
... References Parkinsonism — Cleveland Clinic Epidemiology, Pathogenesis, and Genetics of Parkinson Disease — Wolters Kluwer UpToDate Initial Pharmacologic Treatment of Parkinson Disease — Wolters Kluwer UpToDate Levodopa — Parkinson’s Foundation Device-Assisted and Lesioning Procedures for Parkinson Disease — Wolters Kluwer UpToDate COMT Inhibitors — ...
... Dyskinesias in Parkinson’s Disease — Brain Levodopa-Induced Dyskinesia in Parkinson Disease: Sleep Matters — Annals of Neurology The Treatment of Sleep Disorders in Parkinson’s Disease: From Research to Clinical Practice — Frontiers in Neurology Therapeutic Strategies To Prevent and Manage Dyskinesias in Parkinson’s Disease — Expert Opinion on Drug Safety COMT ...
Sleep and Dyskinesia: What’s the Connection?
... Dyskinesias in Parkinson’s Disease — Brain Levodopa-Induced Dyskinesia in Parkinson Disease: Sleep Matters — Annals of Neurology The Treatment of Sleep Disorders in Parkinson’s Disease: From Research to Clinical Practice — Frontiers in Neurology Therapeutic Strategies To Prevent and Manage Dyskinesias in Parkinson’s Disease — Expert Opinion on Drug Safety COMT ...
... Specialized enzymes known as catechol-O-methyltransferase (COMT) inhibitors can also be used to increase the amount of levodopa that reaches the brain. Dopamine AgonistsDopamine agonists are drugs that mimic the shape and function of dopamine. Unlike levodopa, dopamine agonists aren’t converted to dopamine. ...
Understanding Dopamine and Parkinson’s Disease
... Specialized enzymes known as catechol-O-methyltransferase (COMT) inhibitors can also be used to increase the amount of levodopa that reaches the brain. Dopamine AgonistsDopamine agonists are drugs that mimic the shape and function of dopamine. Unlike levodopa, dopamine agonists aren’t converted to dopamine. ...
... Parkinson’s disease symptoms are caused by low levels of dopamine in the brain.Dopaminergic medications include: Levodopa/carbidopa (Crexont, Duopa, Rytary, Sinemet) Levodopa (Inbrija) Levodopa/carbidopa/entacapone (Stalevo) Catechol-O-methyltransferase (COMT) inhibitors such as entacapone (Comtan), opicapone (Ongentys), and tolcapone (Tasmar; rarely ...
Side Effects of Parkinson’s Disease Treatment
... Parkinson’s disease symptoms are caused by low levels of dopamine in the brain.Dopaminergic medications include: Levodopa/carbidopa (Crexont, Duopa, Rytary, Sinemet) Levodopa (Inbrija) Levodopa/carbidopa/entacapone (Stalevo) Catechol-O-methyltransferase (COMT) inhibitors such as entacapone (Comtan), opicapone (Ongentys), and tolcapone (Tasmar; rarely ...
... Catechol-o-methyltransferase (COMT) inhibitors — These add-on treatments extend each levodopa dose. Examples include entacapone (Comtan), levodopa/carbidopa/entacapone (Stalevo), opicapone (Ongentys), and tolcapone (Tasmar). Dopamine agonists — These can be taken alone or with other medications to mimic dopamine in the brain. ...
Managing Parkinson's Disease Motor Fluctuations
... Catechol-o-methyltransferase (COMT) inhibitors — These add-on treatments extend each levodopa dose. Examples include entacapone (Comtan), levodopa/carbidopa/entacapone (Stalevo), opicapone (Ongentys), and tolcapone (Tasmar). Dopamine agonists — These can be taken alone or with other medications to mimic dopamine in the brain. ...
Join
